Simon Peter Cooper - Net Worth and Insider Trading
Simon Peter Cooper Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Simon Peter Cooper owns 1 companies in total, including Keros Therapeutics Inc (KROS) .
Click here to see the complete history of Simon Peter Cooper’s form 4 insider trades.
Insider Ownership Summary of Simon Peter Cooper
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KROS | Keros Therapeutics Inc | 2021-08-02 | Chief Medical Officer |
Simon Peter Cooper Trading Performance
Simon Peter Cooper Ownership Network
Simon Peter Cooper Owned Company Details
What does Keros Therapeutics Inc do?
Who are the key executives at Keros Therapeutics Inc?
Simon Peter Cooper is the Chief Medical Officer of Keros Therapeutics Inc. Other key executives at Keros Therapeutics Inc include Chief Financial Officer Keith Regnante , Chief Scientific Officer Jennifer Lachey , and Chief Operating Officer Christopher Rovaldi .
Keros Therapeutics Inc (KROS) Insider Trades Summary
Over the past 18 months, Simon Peter Cooper made no insider transaction in Keros Therapeutics Inc (KROS). Other recent insider transactions involving Keros Therapeutics Inc (KROS) include a net sale of 250,000 shares made by Carl L Gordon , a net sale of 250,000 shares made by Orbimed Advisors Llc , and a net sale of 40,000 shares made by Keith Regnante .
In summary, during the past 3 months, insiders sold 0 shares of Keros Therapeutics Inc (KROS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 540,000 shares of Keros Therapeutics Inc (KROS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 540,000 shares.
Keros Therapeutics Inc (KROS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Keros Therapeutics Inc Insider Transactions
Simon Peter Cooper Mailing Address
Above is the net worth, insider trading, and ownership report for Simon Peter Cooper. You might contact Simon Peter Cooper via mailing address: C/o Keros Therapeutics, Inc., 99 Hayden Ave., Building E, Suite 120, Lexington Ma 02421.